Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in ER+ early stage breast cancer
NCT03168074Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Mar 2017
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib in estrogen receptor-positive breast cancer (ER+), sponsored by National University Hospital. Status: unknown.
02
Drugs
lenvatinib
03
Conditions
estrogen receptor-positive breast cancer (ER+)
Beyond the preview
Go deeper on NCT03168074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03168074.